Nano-Enhanced Antibiotic Delivery for Skin Cancer Treatment: A Breakthrough in Nanomedicine
Main Article Content
Keywords
Nanomedicine, Antibiotic, Skin Cancer , Skin radiation
Abstract
Skin cancer is a major global health concern for which there is a lack of efficacy in conventional treatment approaches because of systemic toxicity and low pharmaceutical efficacy, among other reasons. By enabling customized medicine delivery to cancer cells with minimal negative effects on healthy elements, nanotechnology has emerged as an effective solution to these issues. The tutorial provides an overview of current breakthroughs in nanotechnologybased medication delivery methods for treating skin cancer. Diverse kinds of nanocarriers, among them liposomes, nanoparticles, and micelles, have unique advantages such extended circulation and the capacity to encapsulate medications that are both impermeable and hydrophilic in character .These characteristics enable the exact delivery of therapeutic medications to lesions of skin cancer. Graphene, silica, and polymers are just a few of the several nanomaterials that have been utilized to construct carriers with various characteristics. Surface functionalization of nanocarriers also allows targeted distribution to cancer cells via ligand-receptor interactions or reaction to environmental stimuli. Reducing adverse effects and improving treatment effectiveness, smart nanosystems precisely boost medicine release at the tumour location. Temperature, light, and pH are just a few of the factors that affect them. Nanotechnology allows for the delivery of both conventional chemotherapeutic medications and novel treatment modalities including gene therapy, Skin radiation therapy for cancer may now be approached in a more comprehensive way thanks to immunotherapeutics and small interfering RNA (siRNA). By presenting the most recent advancements in preclinical and clinical research, this talk emphasises the potential of nanotechnology in resolving the challenges associated with skin cancer treatment. Due to its enhanced therapeutic outcomes, less systemic toxicity, and higher drug delivery efficiency, nanotechnology presents a promising approach for developing new and effective treatments for skin cancer. The ongoing research in this field has led to optimistic expectations for the future of tailored and targeted therapy for patients with skin cancer.
References
1. Khan NH, Mir M, Qian L, et al. Skin cancer biology and barriers to treatment: Recent applications of polymeric micro/ nanostructures. Journal of Advanced Research. 2022;36:223-247.
2. Urban K, Mehrmal S, Uppal P, Giesey RL, Delost GR. The global burden of skin cancer: A longitudinal analysis from the Global Burden of Disease Study, 1990–2017. JAAD international. 2021;2:98-108.
3. Adnan M, Akhter MH, Afzal O, et al. Exploring Nanocarriers as Treatment Modalities for Skin Cancer. Molecules. 2023;28(15):5905.
4. Schneider S, Ferte T, Ducharme O, et al. Improved survival over time with immunotherapy in locally advanced and metastatic cutaneous squamous cell carcinomas. 2023.
5. Egambaram OP, Kesavan Pillai S, Ray SS. Materials science challenges in skin UV protection: A review. Photochemistry and photobiology. 2020;96(4):779-797.
6. Roberts MS, Cheruvu HS, Mangion SE, et al. Topical drug delivery: History, percutaneous absorption, and product development. Advanced drug delivery reviews. 2021;177:113929.
7. Lalotra AS, Singh V, Khurana B, Agrawal S, Shrestha S, Arora D. A comprehensive review on nanotechnology-based innovations in topical drug delivery for the treatment of skin cancer. Current Pharmaceutical Design. 2020;26(44):5720-5731.
8. Verstockt J, Verspeek S, Thiessen F, Tjalma WA, Brochez L, Steenackers G. Skin cancer detection using infrared thermography: Measurement setup, procedure and equipment. Sensors. 2022;22(9):3327.
9. Labani S, Asthana S, Rathore K, Sardana K. Incidence of melanoma and nonmelanoma skin cancers in Indian and the global regions. Journal of cancer research and therapeutics. 2021;17(4):906-911.
10. Carr S, Smith C, Wernberg J. Epidemiology and risk factors of melanoma. Surgical Clinics. 2020;100(1):1-12.
11. Boczar D, Restrepo DJ, Sisti A, et al. Disparity on unplanned readmission in melanoma patients: a National Cancer Database analysis. Anticancer research. 2019;39(12):6877-6880.
12. Zheng Y, Li Z, Chen H, Gao Y. Nanoparticle-based drug delivery systems for controllable photodynamic cancer therapy. European Journal of Pharmaceutical Sciences. 2020;144:105213.
13. Kumari S, Choudhary PK, Shukla R, Sahebkar A, Kesharwani P. Recent advances in nanotechnology based combination drug therapy for skin cancer. Journal of Biomaterials Science, Polymer Edition. 2022;33(11):1435-1468.
14. Liao J, Peng H, Wei X, et al. A bio-responsive 6-mercaptopurine/doxorubicin based “Click Chemistry” polymeric prodrug for cancer therapy. Materials Science and Engineering: C. 2020;108:110461.
15. Liao J, Peng H, Liu C, et al. Dual pH-responsive-charge-reversal micelle platform for enhanced anticancer therapy. Materials Science and Engineering: C. 2021;118:111527.
16. Agrawal M, Saraf S, Saraf S, et al. Stimuli-responsive In situ gelling system for nose-to-brain drug delivery. Journal of Controlled Release. 2020;327:235-265.
17. Borgheti-Cardoso LN, Viegas JSR, Silvestrini AVP, et al. Nanotechnology approaches in the current therapy of skin cancer. Advanced Drug Delivery Reviews. 2020;153:109-136.
18. Trinh HT, Mohanan S, Radhakrishnan D, et al. Silica-based nanomaterials as drug delivery tools for skin cancer (melanoma) treatment. Emergent Materials. 2021;4(5):1067-1092.
19. Ostrowski SM, Fisher DE. Biology of melanoma. Hematology/Oncology Clinics. 2021;35(1):29-56.
20. Sreelatha T, Subramanyam M, Prasad M. A survey work on early detection methods of melanoma skin cancer. Research Journal of Pharmacy and Technology. 2019;12(5):2589-2596.
21. Krishnan V, Mitragotri S. Nanoparticles for topical drug delivery: Potential for skin cancer treatment. Advanced Drug Delivery Reviews. 2020;153:87-108.
22. Yousef H, Alhajj M, Sharma S. Anatomy, skin (integument), epidermis. 2017.
23. Berghe AS, Cobzac G, Dindelegan G, et al. Risk factors for positive sentinel lymph node, lymphatic or hematogenous dissemination over time in patients with cutaneous melanoma. Experimental and Therapeutic Medicine. 2021;22(1):1-8.
24. Khazaei Z, Ghorat F, Jarrahi A, Adineh H, Sohrabivafa M, Goodarzi E. Global incidence and mortality of skin cancer by histological subtype and its relationship with the human development index (HDI); an ecology study in 2018. World Cancer Res J. 2019;6(2):e13.
25. Kato J, Horimoto K, Sato S, Minowa T, Uhara H. Dermoscopy of melanoma and non-melanoma skin cancers. Frontiers in medicine. 2019;6:180.
26. Fine GC, Covington MF, Koppula BR, et al. PET-CT in Clinical Adult Oncology—VI. Primary Cutaneous Cancer, Sarcomas and Neuroendocrine Tumors. Cancers. 2022;14(12):2835.
27. Eddy K, Chen S. Overcoming immune evasion in melanoma. International journal of molecular sciences. 2020;21(23):8984.
28. Arslanbaeva LR, Santoro MM. Adaptive redox homeostasis in cutaneous melanoma. Redox biology. 2020;37:101753.
29. Zhou S, Han Y, Yang R, Pi X, Li J. TIMM13 as a prognostic biomarker and associated with immune infiltration in skin cutaneous melanoma (SKCM). Frontiers in Surgery. 2022;9:990749.
30. Strashilov S, Yordanov A. Aetiology and pathogenesis of cutaneous melanoma: current concepts and advances. International journal of molecular sciences. 2021;22(12):6395.
31. Vergara IA, Wilmott JS, Long GV, Scolyer RA. Genetic drivers of non‐cutaneous melanomas: Challenges and opportunities in a heterogeneous landscape. Experimental Dermatology. 2022;31(1):13-30.
32. Saidi B, Fallahi B, Fard-Esfahani A, Emami-Ardekani A, Eftekhari M. Non-Cutaneous Melanoma, Findings and Prognostic Value of FDG PET/CT: A Case Series of 23 patients and review of the literature. Asia Oceania Journal of Nuclear Medicine and Biology. 2022;10(2):91.
33. Conte S, Lagacé F, Ghazawi FM, et al. Uveal melanoma incidence trends in Canada: 1992–2010 vs. 2011–2017. Frontiers in Medicine. 2023;9:1001799.
34. Ciążyńska M, Kamińska-Winciorek G, Lange D, et al. The incidence and clinical analysis of non-melanoma skin cancer. Scientific reports. 2021;11(1):4337.
35. Shalhout SZ, Kaufman HL, Emerick KS, Miller DM. Immunotherapy for Nonmelanoma skin cancer: Facts and Hopes. Clinical
Cancer Research. 2022;28(11):2211-2220.
36. Fitzmauric C, Fitzmaurice C, Abate D, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study. JAMA Oncology. 2019;5(12):1749-1768.
37. Goyal M, Knackstedt T, Yan S, Hassanpour S. Artificial intelligence-based image classification methods for diagnosis of skin cancer: Challenges and opportunities. Computers in biology and medicine. 2020;127:104065.
38. Villani A, Fabbrocini G, Costa C, Carmela Annunziata M, Scalvenzi M. Merkel cell carcinoma: therapeutic update and emerging therapies. Dermatology and Therapy. 2019;9:209-222.
39. Ogawa T, Donizy P, Wu C-L, Cornejo KM, Rys J, Hoang MP. Morphologic diversity of Merkel cell carcinoma. The American Journal of Dermatopathology. 2020;42(9):629-640.
40. Walsh NM, Cerroni L. Merkel cell carcinoma: A review. Journal of Cutaneous Pathology. 2021;48(3):411-421.
41. Zwijnenburg EM, Lubeek SF, Werner JE, et al. Merkel cell carcinoma: New trends. Cancers. 2021;13(7):1614.
42. Patel P, Hussain K. Merkel cell carcinoma. Clinical and Experimental Dermatology. 2021;46(5):814-819.
43. DeCaprio JA. Molecular pathogenesis of Merkel cell carcinoma. Annual Review of Pathology: Mechanisms of Disease. 2021;16:69-91.
44. Rabinowits G, Lezcano C, Catalano PJ, et al. Cabozantinib in patients with advanced Merkel cell carcinoma. The oncologist. 2018;23(7):814-821.
45. Knepper TC, Montesion M, Russell JS, et al. The genomic landscape of Merkel cell carcinoma and clinicogenomic biomarkers of response to immune checkpoint inhibitor therapy. Clinical Cancer Research. 2019;25(19):5961-5971.
46. Waldman A, Schmults C. Cutaneous squamous cell carcinoma. Hematology/Oncology Clinics. 2019;33(1):1-12.
47. Stratigos AJ, Garbe C, Dessinioti C, et al. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and prevention. European journal of cancer. 2020;128:60-82.
48. Nagarajan P, Asgari MM, Green AC, et al. Keratinocyte carcinomas: current concepts and future research priorities. Clinical Cancer Research. 2019;25(8):2379-2391.
49. Ronconi G, Piccinni C, Dondi L, et al. Identification of cases and estimate of direct costs of unresectable and advanced cutaneous squamous cell carcinoma: real‐world data from a large Italian database. British Journal of Dermatology. 2020;183(1):172-174.
50. Ruiz ES, Karia PS, Besaw R, Schmults CD. Performance of the American Joint Committee on Cancer Staging Manual, vs the Brigham and Women’s Hospital tumor classification system for cutaneous squamous cell carcinoma. JAMA dermatology. 2019;155(7):819-825.
51. Dika E, Scarfì F, Ferracin M, et al. Basal cell carcinoma: a comprehensive review. International journal of molecular sciences. 2020;21(15):5572.
52. Sreekantaswamy S, Endo J, Chen A, Butler D, Morrison L, Linos E. Aging and the treatment of basal cell carcinoma. Clinics in dermatology. 2019;37(4):373-378.
53. Bassukas ID, Tatsioni A. Male sex is an inherent risk factor for basal cell carcinoma. Journal of Skin Cancer. 2019;2019.
54. De Giorgi V, Salvati L, Barchielli A, et al. The burden of cutaneous adnexal carcinomas and the risk of associated squamous cell carcinoma: a population‐based study. British Journal of Dermatology. 2019;180(3):565-573.
55. Libertini M, Oneda E, Di Biasi B, Savelli G, Zaniboni A. Cutaneous Adnexal Carcinoma with Apocrine Differentiation: A Challenging Diagnosis and Personalized Treatment with mTOR Inhibitor in a Very Rare Disease. Case Reports in Oncology. 2021;13(3):1091-1096.
56. McKenzie C, Silverberg JI. Association of family structure with atopic dermatitis in US children. Journal of the American Academy of Dermatology. 2018;79(4):638-644. e634.
57. Safwat MA, Soliman GM, Sayed D, Attia MA. Fluorouracil-loaded gold nanoparticles for the treatment of skin cancer: development, in vitro characterization, and in vivo evaluation in a mouse skin cancer xenograft model. Molecular pharmaceutics. 2018;15(6):2194-2205.
58. Mohammad O, Faisal SM, Ahmad N, et al. Bio-mediated synthesis of 5-FU based nanoparticles employing orange fruit juice: a novel drug delivery system to treat skin fibrosarcoma in model animals. Scientific Reports. 2019;9(1):12288.
59. Suh HW, Lewis J, Fong L, et al. Biodegradable bioadhesive nanoparticle incorporation of broad‐spectrum organic sunscreen agents. Bioengineering & translational medicine. 2019;4(1):129-140.
60. Chen H, Hou K, Yu J, Wang L, Chen X. Nanoparticle-based combination therapy for melanoma. Frontiers in Oncology. 2022;12:928797.
61. Chaturvedi VK, Singh A, Singh VK, Singh MP. Cancer nanotechnology: a new revolution for cancer diagnosis and therapy. Current drug metabolism. 2019;20(6):416-429.
62. Wang J, Sui L, Huang J, et al. MoS2-based nanocomposites for cancer diagnosis and therapy. Bioactive Materials. 2021;6(11):4209-4242.
63. Van Straten D, Mashayekhi V, De Bruijn HS, Oliveira S, Robinson DJ. Oncologic photodynamic therapy: basic principles, current clinical status and future directions. Cancers. 2017;9(2):19.
64. Rady M, Gomaa I, Afifi N, Abdel-Kader M. Dermal delivery of Fe-chlorophyllin via ultradeformable nanovesicles for photodynamic therapy in melanoma animal model. International Journal of Pharmaceutics. 2018;548(1):480-490.
65. Bazylińska U, Kulbacka J, Schmidt J, Talmon Y, Murgia S. Polymer-free cubosomes for simultaneous bioimaging and photodynamic action of photosensitizers in melanoma skin cancer cells. Journal of colloid and interface science. 2018;522:163-173.
66. Rahimi-Moghaddam F, Azarpira N, Sattarahmady N. Evaluation of a nanocomposite of PEG-curcumin-gold nanoparticles as a near-infrared photothermal agent: An in vitro and animal model investigation. Lasers in medical science. 2018;33:1769-1779.
67. Wang Z, Zhang Y, Cao B, et al. Explosible nanocapsules excited by pulsed microwaves for efficient thermoacoustic-chemo combination therapy. Nanoscale. 2019;11(4):1710-1719.
68. Gavas S, Quazi S, Karpiński TM. Nanoparticles for cancer therapy: current progress and challenges. Nanoscale research letters. 2021;16(1):173.
69. Amreddy N, Babu A, Muralidharan R, et al. Recent advances in nanoparticle-based cancer drug and gene delivery. Advances in cancer research. 2018;137:115-170.
70. Rajak BL, Kumar R, Gogoi M, Patra S. Antimicrobial activity of nanomaterials. Nanoscience in Medicine Vol 1. 2020:147-185.
71. Pancholi R, Jain S. Different Aspects of Nano-material and Biodegradable Polymers for Cancer Diagnosis and Treatment: A. 2022.
72. Khanna N, Chatterji T, Singh S, Pandey S. Application of stimuli responsive nanocomposites in drug delivery and theranostics to counter cancer proliferation and drug resistance. Journal of Drug Delivery Science and Technology. 2023:104958.
73. Dubey SK, Salunkhe S, Agrawal M, et al. Understanding the pharmaceutical aspects of dendrimers for the delivery of anticancer drugs. Current Drug Targets. 2020;21(6):528-540.
74. Cook AB, Perrier S. Branched and dendritic polymer architectures: Functional nanomaterials for therapeutic delivery. Advanced Functional Materials. 2020;30(2):1901001.
75. Lim J, Kostiainen M, Maly J, et al. Synthesis of large dendrimers with the dimensions of small viruses. Journal of the American Chemical Society. 2013;135(12):4660-4663.
76. Zahavi D, Weiner L. Monoclonal antibodies in cancer therapy. Antibodies. 2020;9(3):34.
77. Sievers EL, Senter PD. Antibody-drug conjugates in cancer therapy. Annual review of medicine. 2013;64:15-29.
78. Pegtel DM, Gould SJ. Exosomes. Annual review of biochemistry. 2019;88:487-514.
79. Nsairat H, Khater D, Sayed U, Odeh F, Al Bawab A, Alshaer W. Liposomes: Structure, composition, types, and clinical applications. Heliyon. 2022.
80. Kansız S, Elçin YM. Advanced liposome and polymersome-based drug delivery systems: Considerations for physicochemical properties, targeting strategies and stimuli-sensitive approaches. Advances in Colloid and Interface Science. 2023:102930.
81. Priya S, Desai VM, Singhvi G. Surface modification of lipid-based nanocarriers: A potential approach to enhance targeted drug delivery. ACS omega. 2022;8(1):74-86.
82. Saraf S, Jain A, Tiwari A, Verma A, Panda PK, Jain SK. Advances in liposomal drug delivery to cancer: An overview. Journal of drug delivery science and technology. 2020;56:101549.
83. Mishra V, Bansal KK, Verma A, et al. Solid lipid nanoparticles: Emerging colloidal nano drug delivery systems. Pharmaceutics. 2018;10(4):191.
84. Paliwal R, Paliwal SR, Kenwat R, Kurmi BD, Sahu MK. Solid lipid nanoparticles: A review on recent perspectives and patents. Expert opinion on therapeutic patents. 2020;30(3):179-194.
85. Musielak E, Feliczak-Guzik A, Nowak I. Optimization of the conditions of solid lipid nanoparticles (SLN) synthesis. Molecules. 2022;27(7):2202.
86. Anthony DP, Hegde M, Shetty SS, Rafic T, Mutalik S, Rao BS. Targeting receptor-ligand chemistry for drug delivery across bloodbrain barrier in brain diseases. Life sciences. 2021;274:119326.
87. Satapathy MK, Yen T-L, Jan J-S, et al. Solid lipid nanoparticles (SLNs): an advanced drug delivery system targeting brain through BBB. Pharmaceutics. 2021;13(8):1183.
88. Saputri D, Jan’ah A, Saraswati T. Synthesis of carbon nanotubes (CNT) by chemical vapor deposition (CVD) using a biogas-based carbon precursor: a review. Paper presented at: IOP Conference Series: Materials Science and Engineering, 2020.
89. Hussain CM. Handbook of nanomaterials for industrial applications: Elsevier; 2018.
90. Abdallah B, Elhissi AM, Ahmed W, Najlah M. Carbon nanotubes drug delivery system for cancer treatment. Advances in Medical and Surgical Engineering: Elsevier; 2020:313-332.
91. Kumar DS, Kumar BJ, Mahesh H. Quantum nanostructures (QDs): an overview. Synthesis of inorganic nanomaterials. 2018:59-88.
92. Gidwani B, Sahu V, Shukla SS, et al. Quantum dots: Prospectives, toxicity, advances and applications. Journal of Drug Delivery Science and Technology. 2021;61:102308.
93. Martelli S, Chow JC. Dose enhancement for the flattening-filter-free and flattening-filter photon beams in nanoparticleenhanced radiotherapy: A Monte Carlo phantom study. Nanomaterials. 2020;10(4):637.
94. Abdulle A, Chow JC. Contrast enhancement for portal imaging in nanoparticle-enhanced radiotherapy: A Monte Carlo phantom evaluation using flattening-filter-free photon beams. Nanomaterials. 2019;9(7):920.
95. Wang W, Wang J, Ding Y. Gold nanoparticle-conjugated nanomedicine: design, construction, and structure–efficacy relationship studies. Journal of Materials Chemistry B. 2020;8(22):4813-4830.
96. Siddique S, Chow JC. Gold nanoparticles for drug delivery and cancer therapy. Applied Sciences. 2020;10(11):3824.
97. Ibaraki H, Kanazawa T, Oogi C, Takashima Y, Seta Y. Effects of surface charge and flexibility of liposomes on dermal drug delivery. Journal of drug delivery science and technology. 2019;50:155-162.
98. Lasoń E. Topical administration of terpenes encapsulated in nanostructured lipid-based systems. Molecules. 2020;25(23):5758.
99. Kauslya A, Borawake PD, Shinde JV, Chavan RS. Niosomes: a novel carrier drug delivery system. Journal of Drug Delivery and Therapeutics. 2021;11(1):162-170.
100. Chaurasiya P, Ganju E, Upmanyu N, Ray SK, Jain P. Transfersomes: a novel technique for transdermal drug delivery. Journal of drug delivery and therapeutics. 2019;9(1):279-285.
101. Kumar N, Dubey A, Mishra A, Tiwari P. Ethosomes: A Novel Approach in Transdermal Drug Delivery System. International journal of pharmacy & life sciences. 2020;11(5).
102. Chauhan N, Vasava P, Khan SL, et al. Ethosomes: A novel drug carrier. Annals of Medicine and Surgery. 2022:104595.
103. Maxwell A, Priya S. Nanosized Ethosomes–A promising vesicular drug carrier for transdermal drug delivery. Research Journal of pharmacy and technology. 2019;12(2):876-880.
104. Duan Y, Dhar A, Patel C, et al. A brief review on solid lipid nanoparticles: Part and parcel of contemporary drug delivery systems. RSC advances. 2020;10(45):26777-26791.
105. Samimi S, Maghsoudnia N, Eftekhari RB, Dorkoosh F. Lipid-based nanoparticles for drug delivery systems. Characterization and biology of nanomaterials for drug delivery. 2019:47-76.
106. Salvi VR, Pawar P. Nanostructured lipid carriers (NLC) system: A novel drug targeting carrier. Journal of Drug Delivery Science and Technology. 2019;51:255-267.
107. Waghule T, Rapalli VK, Gorantla S, et al. Nanostructured lipid carriers as potential drug delivery systems for skin disorders. Current Pharmaceutical Design. 2020;26(36):4569-4579.
108. Majumder N, G Das N, Das SK. Polymeric micelles for anticancer drug delivery. Therapeutic delivery. 2020;11(10):613-635.
109. Fang C-L, Aljuffali IA, Li Y-C, Fang J-Y. Delivery and targeting of nanoparticles into hair follicles. Therapeutic delivery 2014;5(9):991-1006.
110. Pelegrino M, Weller R, Chen X, Bernardes J, Seabra AB. Chitosan nanoparticles for nitric oxide delivery in human skin. MedChemComm. 2017;8(4):713-719.
111. Zhang Z, Tsai PC, Ramezanli T, Michniak‐Kohn BB. Polymeric nanoparticles‐based topical delivery systems for the treatment of dermatological diseases. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology. 2013;5(3):205-218.
112. Sun L, Liu Z, Wang L, et al. Enhanced topical penetration, system exposure and anti-psoriasis activity of two particle-sized, curcumin-loaded PLGA nanoparticles in hydrogel. Journal of Controlled Release. 2017;254:44-54.
113. Ramezanli T, Kilfoyle BE, Zhang Z, Michniak-Kohn BB. Polymeric nanospheres for topical delivery of vitamin D3. International Journal of Pharmaceutics. 2017;516(1-2):196-203.
114. Tabarzad M, Ghorbani-Bidkorbeh F. Dendrimers formulations to enhance skin drug delivery. Dendrimer-based nanotherapeutics: Elsevier; 2021:399-416.
115. Karthik P, Ezhilarasi P, Anandharamakrishnan C. Challenges associated in stability of food grade nanoemulsions. Critical reviews in food science and nutrition. 2017;57(7):1435-1450.
116. Belhaj N, Arab-Tehrany E, Linder M. Oxidative kinetics of salmon oil in bulk and in nanoemulsion stabilized by marine lecithin. Process Biochemistry. 2010;45(2):187-195.
117. Rehman FU, Shah KU, Shah SU, Khan IU, Khan GM, Khan A. From nanoemulsions to self-nanoemulsions, with recent advances in self-nanoemulsifying drug delivery systems (SNEDDS). Expert opinion on drug delivery. 2017;14(11):1325-1340.
118. Kamble P, Sadarani B, Majumdar A, Bhullar S. Nanofiber based drug delivery systems for skin: A promising therapeutic approach. Journal of Drug Delivery Science and Technology. 2017;41:124-133.
119. Rasouli R, Barhoum A, Bechelany M, Dufresne A. Nanofibers for biomedical and healthcare applications. Macromolecular bioscience. 2019;19(2):1800256.
120. Niu J, Chu Y, Huang Y-F, et al. Transdermal gene delivery by functional peptide-conjugated cationic gold nanoparticle reverses the progression and metastasis of cutaneous melanoma. ACS applied materials & interfaces. 2017;9(11):9388-9401.
121. Kumar H, Venkatesh N, Bhowmik H, Kuila A. Metallic nanoparticle: a review. Biomed J Sci Tech Res. 2018;4(2):3765-3775.
122. Rai M, Ingle AP, Birla S, Yadav A, Santos CAD. Strategic role of selected noble metal nanoparticles in medicine. Critical reviews in microbiology. 2016;42(5):696-719.
123. Iv M, Telischak N, Feng D, Holdsworth SJ, Yeom KW, Daldrup-Link HE. Clinical applications of iron oxide nanoparticles for magnetic resonance imaging of brain tumors. Nanomedicine. 2015;10(6):993-1018.
124. Nasrollahzadeh M, Sajadi SM. Green synthesis of copper nanoparticles using Ginkgo biloba L. leaf extract and their catalytic activity for the Huisgen [3+ 2] cycloaddition of azides and alkynes at room temperature. Journal of colloid and interface science. 2015;457:141-147.
125. Alsareii SA, Manaa Alamri A, AlAsmari MY, et al. Synthesis and characterization of silver nanoparticles from Rhizophora apiculate and studies on their wound healing, antioxidant, anti-inflammatory, and cytotoxic activity. Molecules. 2022;27(19):6306.
126. Shnoudeh AJ, Hamad I, Abdo RW, et al. Synthesis, characterization, and applications of metal nanoparticles. Biomaterials and bionanotechnology: Elsevier; 2019:527-612.
127. Begum SJ, Pratibha S, Rawat JM, et al. Recent advances in green synthesis, characterization, and applications of bioactive metallic nanoparticles. Pharmaceuticals. 2022;15(4):455.
2. Urban K, Mehrmal S, Uppal P, Giesey RL, Delost GR. The global burden of skin cancer: A longitudinal analysis from the Global Burden of Disease Study, 1990–2017. JAAD international. 2021;2:98-108.
3. Adnan M, Akhter MH, Afzal O, et al. Exploring Nanocarriers as Treatment Modalities for Skin Cancer. Molecules. 2023;28(15):5905.
4. Schneider S, Ferte T, Ducharme O, et al. Improved survival over time with immunotherapy in locally advanced and metastatic cutaneous squamous cell carcinomas. 2023.
5. Egambaram OP, Kesavan Pillai S, Ray SS. Materials science challenges in skin UV protection: A review. Photochemistry and photobiology. 2020;96(4):779-797.
6. Roberts MS, Cheruvu HS, Mangion SE, et al. Topical drug delivery: History, percutaneous absorption, and product development. Advanced drug delivery reviews. 2021;177:113929.
7. Lalotra AS, Singh V, Khurana B, Agrawal S, Shrestha S, Arora D. A comprehensive review on nanotechnology-based innovations in topical drug delivery for the treatment of skin cancer. Current Pharmaceutical Design. 2020;26(44):5720-5731.
8. Verstockt J, Verspeek S, Thiessen F, Tjalma WA, Brochez L, Steenackers G. Skin cancer detection using infrared thermography: Measurement setup, procedure and equipment. Sensors. 2022;22(9):3327.
9. Labani S, Asthana S, Rathore K, Sardana K. Incidence of melanoma and nonmelanoma skin cancers in Indian and the global regions. Journal of cancer research and therapeutics. 2021;17(4):906-911.
10. Carr S, Smith C, Wernberg J. Epidemiology and risk factors of melanoma. Surgical Clinics. 2020;100(1):1-12.
11. Boczar D, Restrepo DJ, Sisti A, et al. Disparity on unplanned readmission in melanoma patients: a National Cancer Database analysis. Anticancer research. 2019;39(12):6877-6880.
12. Zheng Y, Li Z, Chen H, Gao Y. Nanoparticle-based drug delivery systems for controllable photodynamic cancer therapy. European Journal of Pharmaceutical Sciences. 2020;144:105213.
13. Kumari S, Choudhary PK, Shukla R, Sahebkar A, Kesharwani P. Recent advances in nanotechnology based combination drug therapy for skin cancer. Journal of Biomaterials Science, Polymer Edition. 2022;33(11):1435-1468.
14. Liao J, Peng H, Wei X, et al. A bio-responsive 6-mercaptopurine/doxorubicin based “Click Chemistry” polymeric prodrug for cancer therapy. Materials Science and Engineering: C. 2020;108:110461.
15. Liao J, Peng H, Liu C, et al. Dual pH-responsive-charge-reversal micelle platform for enhanced anticancer therapy. Materials Science and Engineering: C. 2021;118:111527.
16. Agrawal M, Saraf S, Saraf S, et al. Stimuli-responsive In situ gelling system for nose-to-brain drug delivery. Journal of Controlled Release. 2020;327:235-265.
17. Borgheti-Cardoso LN, Viegas JSR, Silvestrini AVP, et al. Nanotechnology approaches in the current therapy of skin cancer. Advanced Drug Delivery Reviews. 2020;153:109-136.
18. Trinh HT, Mohanan S, Radhakrishnan D, et al. Silica-based nanomaterials as drug delivery tools for skin cancer (melanoma) treatment. Emergent Materials. 2021;4(5):1067-1092.
19. Ostrowski SM, Fisher DE. Biology of melanoma. Hematology/Oncology Clinics. 2021;35(1):29-56.
20. Sreelatha T, Subramanyam M, Prasad M. A survey work on early detection methods of melanoma skin cancer. Research Journal of Pharmacy and Technology. 2019;12(5):2589-2596.
21. Krishnan V, Mitragotri S. Nanoparticles for topical drug delivery: Potential for skin cancer treatment. Advanced Drug Delivery Reviews. 2020;153:87-108.
22. Yousef H, Alhajj M, Sharma S. Anatomy, skin (integument), epidermis. 2017.
23. Berghe AS, Cobzac G, Dindelegan G, et al. Risk factors for positive sentinel lymph node, lymphatic or hematogenous dissemination over time in patients with cutaneous melanoma. Experimental and Therapeutic Medicine. 2021;22(1):1-8.
24. Khazaei Z, Ghorat F, Jarrahi A, Adineh H, Sohrabivafa M, Goodarzi E. Global incidence and mortality of skin cancer by histological subtype and its relationship with the human development index (HDI); an ecology study in 2018. World Cancer Res J. 2019;6(2):e13.
25. Kato J, Horimoto K, Sato S, Minowa T, Uhara H. Dermoscopy of melanoma and non-melanoma skin cancers. Frontiers in medicine. 2019;6:180.
26. Fine GC, Covington MF, Koppula BR, et al. PET-CT in Clinical Adult Oncology—VI. Primary Cutaneous Cancer, Sarcomas and Neuroendocrine Tumors. Cancers. 2022;14(12):2835.
27. Eddy K, Chen S. Overcoming immune evasion in melanoma. International journal of molecular sciences. 2020;21(23):8984.
28. Arslanbaeva LR, Santoro MM. Adaptive redox homeostasis in cutaneous melanoma. Redox biology. 2020;37:101753.
29. Zhou S, Han Y, Yang R, Pi X, Li J. TIMM13 as a prognostic biomarker and associated with immune infiltration in skin cutaneous melanoma (SKCM). Frontiers in Surgery. 2022;9:990749.
30. Strashilov S, Yordanov A. Aetiology and pathogenesis of cutaneous melanoma: current concepts and advances. International journal of molecular sciences. 2021;22(12):6395.
31. Vergara IA, Wilmott JS, Long GV, Scolyer RA. Genetic drivers of non‐cutaneous melanomas: Challenges and opportunities in a heterogeneous landscape. Experimental Dermatology. 2022;31(1):13-30.
32. Saidi B, Fallahi B, Fard-Esfahani A, Emami-Ardekani A, Eftekhari M. Non-Cutaneous Melanoma, Findings and Prognostic Value of FDG PET/CT: A Case Series of 23 patients and review of the literature. Asia Oceania Journal of Nuclear Medicine and Biology. 2022;10(2):91.
33. Conte S, Lagacé F, Ghazawi FM, et al. Uveal melanoma incidence trends in Canada: 1992–2010 vs. 2011–2017. Frontiers in Medicine. 2023;9:1001799.
34. Ciążyńska M, Kamińska-Winciorek G, Lange D, et al. The incidence and clinical analysis of non-melanoma skin cancer. Scientific reports. 2021;11(1):4337.
35. Shalhout SZ, Kaufman HL, Emerick KS, Miller DM. Immunotherapy for Nonmelanoma skin cancer: Facts and Hopes. Clinical
Cancer Research. 2022;28(11):2211-2220.
36. Fitzmauric C, Fitzmaurice C, Abate D, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study. JAMA Oncology. 2019;5(12):1749-1768.
37. Goyal M, Knackstedt T, Yan S, Hassanpour S. Artificial intelligence-based image classification methods for diagnosis of skin cancer: Challenges and opportunities. Computers in biology and medicine. 2020;127:104065.
38. Villani A, Fabbrocini G, Costa C, Carmela Annunziata M, Scalvenzi M. Merkel cell carcinoma: therapeutic update and emerging therapies. Dermatology and Therapy. 2019;9:209-222.
39. Ogawa T, Donizy P, Wu C-L, Cornejo KM, Rys J, Hoang MP. Morphologic diversity of Merkel cell carcinoma. The American Journal of Dermatopathology. 2020;42(9):629-640.
40. Walsh NM, Cerroni L. Merkel cell carcinoma: A review. Journal of Cutaneous Pathology. 2021;48(3):411-421.
41. Zwijnenburg EM, Lubeek SF, Werner JE, et al. Merkel cell carcinoma: New trends. Cancers. 2021;13(7):1614.
42. Patel P, Hussain K. Merkel cell carcinoma. Clinical and Experimental Dermatology. 2021;46(5):814-819.
43. DeCaprio JA. Molecular pathogenesis of Merkel cell carcinoma. Annual Review of Pathology: Mechanisms of Disease. 2021;16:69-91.
44. Rabinowits G, Lezcano C, Catalano PJ, et al. Cabozantinib in patients with advanced Merkel cell carcinoma. The oncologist. 2018;23(7):814-821.
45. Knepper TC, Montesion M, Russell JS, et al. The genomic landscape of Merkel cell carcinoma and clinicogenomic biomarkers of response to immune checkpoint inhibitor therapy. Clinical Cancer Research. 2019;25(19):5961-5971.
46. Waldman A, Schmults C. Cutaneous squamous cell carcinoma. Hematology/Oncology Clinics. 2019;33(1):1-12.
47. Stratigos AJ, Garbe C, Dessinioti C, et al. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and prevention. European journal of cancer. 2020;128:60-82.
48. Nagarajan P, Asgari MM, Green AC, et al. Keratinocyte carcinomas: current concepts and future research priorities. Clinical Cancer Research. 2019;25(8):2379-2391.
49. Ronconi G, Piccinni C, Dondi L, et al. Identification of cases and estimate of direct costs of unresectable and advanced cutaneous squamous cell carcinoma: real‐world data from a large Italian database. British Journal of Dermatology. 2020;183(1):172-174.
50. Ruiz ES, Karia PS, Besaw R, Schmults CD. Performance of the American Joint Committee on Cancer Staging Manual, vs the Brigham and Women’s Hospital tumor classification system for cutaneous squamous cell carcinoma. JAMA dermatology. 2019;155(7):819-825.
51. Dika E, Scarfì F, Ferracin M, et al. Basal cell carcinoma: a comprehensive review. International journal of molecular sciences. 2020;21(15):5572.
52. Sreekantaswamy S, Endo J, Chen A, Butler D, Morrison L, Linos E. Aging and the treatment of basal cell carcinoma. Clinics in dermatology. 2019;37(4):373-378.
53. Bassukas ID, Tatsioni A. Male sex is an inherent risk factor for basal cell carcinoma. Journal of Skin Cancer. 2019;2019.
54. De Giorgi V, Salvati L, Barchielli A, et al. The burden of cutaneous adnexal carcinomas and the risk of associated squamous cell carcinoma: a population‐based study. British Journal of Dermatology. 2019;180(3):565-573.
55. Libertini M, Oneda E, Di Biasi B, Savelli G, Zaniboni A. Cutaneous Adnexal Carcinoma with Apocrine Differentiation: A Challenging Diagnosis and Personalized Treatment with mTOR Inhibitor in a Very Rare Disease. Case Reports in Oncology. 2021;13(3):1091-1096.
56. McKenzie C, Silverberg JI. Association of family structure with atopic dermatitis in US children. Journal of the American Academy of Dermatology. 2018;79(4):638-644. e634.
57. Safwat MA, Soliman GM, Sayed D, Attia MA. Fluorouracil-loaded gold nanoparticles for the treatment of skin cancer: development, in vitro characterization, and in vivo evaluation in a mouse skin cancer xenograft model. Molecular pharmaceutics. 2018;15(6):2194-2205.
58. Mohammad O, Faisal SM, Ahmad N, et al. Bio-mediated synthesis of 5-FU based nanoparticles employing orange fruit juice: a novel drug delivery system to treat skin fibrosarcoma in model animals. Scientific Reports. 2019;9(1):12288.
59. Suh HW, Lewis J, Fong L, et al. Biodegradable bioadhesive nanoparticle incorporation of broad‐spectrum organic sunscreen agents. Bioengineering & translational medicine. 2019;4(1):129-140.
60. Chen H, Hou K, Yu J, Wang L, Chen X. Nanoparticle-based combination therapy for melanoma. Frontiers in Oncology. 2022;12:928797.
61. Chaturvedi VK, Singh A, Singh VK, Singh MP. Cancer nanotechnology: a new revolution for cancer diagnosis and therapy. Current drug metabolism. 2019;20(6):416-429.
62. Wang J, Sui L, Huang J, et al. MoS2-based nanocomposites for cancer diagnosis and therapy. Bioactive Materials. 2021;6(11):4209-4242.
63. Van Straten D, Mashayekhi V, De Bruijn HS, Oliveira S, Robinson DJ. Oncologic photodynamic therapy: basic principles, current clinical status and future directions. Cancers. 2017;9(2):19.
64. Rady M, Gomaa I, Afifi N, Abdel-Kader M. Dermal delivery of Fe-chlorophyllin via ultradeformable nanovesicles for photodynamic therapy in melanoma animal model. International Journal of Pharmaceutics. 2018;548(1):480-490.
65. Bazylińska U, Kulbacka J, Schmidt J, Talmon Y, Murgia S. Polymer-free cubosomes for simultaneous bioimaging and photodynamic action of photosensitizers in melanoma skin cancer cells. Journal of colloid and interface science. 2018;522:163-173.
66. Rahimi-Moghaddam F, Azarpira N, Sattarahmady N. Evaluation of a nanocomposite of PEG-curcumin-gold nanoparticles as a near-infrared photothermal agent: An in vitro and animal model investigation. Lasers in medical science. 2018;33:1769-1779.
67. Wang Z, Zhang Y, Cao B, et al. Explosible nanocapsules excited by pulsed microwaves for efficient thermoacoustic-chemo combination therapy. Nanoscale. 2019;11(4):1710-1719.
68. Gavas S, Quazi S, Karpiński TM. Nanoparticles for cancer therapy: current progress and challenges. Nanoscale research letters. 2021;16(1):173.
69. Amreddy N, Babu A, Muralidharan R, et al. Recent advances in nanoparticle-based cancer drug and gene delivery. Advances in cancer research. 2018;137:115-170.
70. Rajak BL, Kumar R, Gogoi M, Patra S. Antimicrobial activity of nanomaterials. Nanoscience in Medicine Vol 1. 2020:147-185.
71. Pancholi R, Jain S. Different Aspects of Nano-material and Biodegradable Polymers for Cancer Diagnosis and Treatment: A. 2022.
72. Khanna N, Chatterji T, Singh S, Pandey S. Application of stimuli responsive nanocomposites in drug delivery and theranostics to counter cancer proliferation and drug resistance. Journal of Drug Delivery Science and Technology. 2023:104958.
73. Dubey SK, Salunkhe S, Agrawal M, et al. Understanding the pharmaceutical aspects of dendrimers for the delivery of anticancer drugs. Current Drug Targets. 2020;21(6):528-540.
74. Cook AB, Perrier S. Branched and dendritic polymer architectures: Functional nanomaterials for therapeutic delivery. Advanced Functional Materials. 2020;30(2):1901001.
75. Lim J, Kostiainen M, Maly J, et al. Synthesis of large dendrimers with the dimensions of small viruses. Journal of the American Chemical Society. 2013;135(12):4660-4663.
76. Zahavi D, Weiner L. Monoclonal antibodies in cancer therapy. Antibodies. 2020;9(3):34.
77. Sievers EL, Senter PD. Antibody-drug conjugates in cancer therapy. Annual review of medicine. 2013;64:15-29.
78. Pegtel DM, Gould SJ. Exosomes. Annual review of biochemistry. 2019;88:487-514.
79. Nsairat H, Khater D, Sayed U, Odeh F, Al Bawab A, Alshaer W. Liposomes: Structure, composition, types, and clinical applications. Heliyon. 2022.
80. Kansız S, Elçin YM. Advanced liposome and polymersome-based drug delivery systems: Considerations for physicochemical properties, targeting strategies and stimuli-sensitive approaches. Advances in Colloid and Interface Science. 2023:102930.
81. Priya S, Desai VM, Singhvi G. Surface modification of lipid-based nanocarriers: A potential approach to enhance targeted drug delivery. ACS omega. 2022;8(1):74-86.
82. Saraf S, Jain A, Tiwari A, Verma A, Panda PK, Jain SK. Advances in liposomal drug delivery to cancer: An overview. Journal of drug delivery science and technology. 2020;56:101549.
83. Mishra V, Bansal KK, Verma A, et al. Solid lipid nanoparticles: Emerging colloidal nano drug delivery systems. Pharmaceutics. 2018;10(4):191.
84. Paliwal R, Paliwal SR, Kenwat R, Kurmi BD, Sahu MK. Solid lipid nanoparticles: A review on recent perspectives and patents. Expert opinion on therapeutic patents. 2020;30(3):179-194.
85. Musielak E, Feliczak-Guzik A, Nowak I. Optimization of the conditions of solid lipid nanoparticles (SLN) synthesis. Molecules. 2022;27(7):2202.
86. Anthony DP, Hegde M, Shetty SS, Rafic T, Mutalik S, Rao BS. Targeting receptor-ligand chemistry for drug delivery across bloodbrain barrier in brain diseases. Life sciences. 2021;274:119326.
87. Satapathy MK, Yen T-L, Jan J-S, et al. Solid lipid nanoparticles (SLNs): an advanced drug delivery system targeting brain through BBB. Pharmaceutics. 2021;13(8):1183.
88. Saputri D, Jan’ah A, Saraswati T. Synthesis of carbon nanotubes (CNT) by chemical vapor deposition (CVD) using a biogas-based carbon precursor: a review. Paper presented at: IOP Conference Series: Materials Science and Engineering, 2020.
89. Hussain CM. Handbook of nanomaterials for industrial applications: Elsevier; 2018.
90. Abdallah B, Elhissi AM, Ahmed W, Najlah M. Carbon nanotubes drug delivery system for cancer treatment. Advances in Medical and Surgical Engineering: Elsevier; 2020:313-332.
91. Kumar DS, Kumar BJ, Mahesh H. Quantum nanostructures (QDs): an overview. Synthesis of inorganic nanomaterials. 2018:59-88.
92. Gidwani B, Sahu V, Shukla SS, et al. Quantum dots: Prospectives, toxicity, advances and applications. Journal of Drug Delivery Science and Technology. 2021;61:102308.
93. Martelli S, Chow JC. Dose enhancement for the flattening-filter-free and flattening-filter photon beams in nanoparticleenhanced radiotherapy: A Monte Carlo phantom study. Nanomaterials. 2020;10(4):637.
94. Abdulle A, Chow JC. Contrast enhancement for portal imaging in nanoparticle-enhanced radiotherapy: A Monte Carlo phantom evaluation using flattening-filter-free photon beams. Nanomaterials. 2019;9(7):920.
95. Wang W, Wang J, Ding Y. Gold nanoparticle-conjugated nanomedicine: design, construction, and structure–efficacy relationship studies. Journal of Materials Chemistry B. 2020;8(22):4813-4830.
96. Siddique S, Chow JC. Gold nanoparticles for drug delivery and cancer therapy. Applied Sciences. 2020;10(11):3824.
97. Ibaraki H, Kanazawa T, Oogi C, Takashima Y, Seta Y. Effects of surface charge and flexibility of liposomes on dermal drug delivery. Journal of drug delivery science and technology. 2019;50:155-162.
98. Lasoń E. Topical administration of terpenes encapsulated in nanostructured lipid-based systems. Molecules. 2020;25(23):5758.
99. Kauslya A, Borawake PD, Shinde JV, Chavan RS. Niosomes: a novel carrier drug delivery system. Journal of Drug Delivery and Therapeutics. 2021;11(1):162-170.
100. Chaurasiya P, Ganju E, Upmanyu N, Ray SK, Jain P. Transfersomes: a novel technique for transdermal drug delivery. Journal of drug delivery and therapeutics. 2019;9(1):279-285.
101. Kumar N, Dubey A, Mishra A, Tiwari P. Ethosomes: A Novel Approach in Transdermal Drug Delivery System. International journal of pharmacy & life sciences. 2020;11(5).
102. Chauhan N, Vasava P, Khan SL, et al. Ethosomes: A novel drug carrier. Annals of Medicine and Surgery. 2022:104595.
103. Maxwell A, Priya S. Nanosized Ethosomes–A promising vesicular drug carrier for transdermal drug delivery. Research Journal of pharmacy and technology. 2019;12(2):876-880.
104. Duan Y, Dhar A, Patel C, et al. A brief review on solid lipid nanoparticles: Part and parcel of contemporary drug delivery systems. RSC advances. 2020;10(45):26777-26791.
105. Samimi S, Maghsoudnia N, Eftekhari RB, Dorkoosh F. Lipid-based nanoparticles for drug delivery systems. Characterization and biology of nanomaterials for drug delivery. 2019:47-76.
106. Salvi VR, Pawar P. Nanostructured lipid carriers (NLC) system: A novel drug targeting carrier. Journal of Drug Delivery Science and Technology. 2019;51:255-267.
107. Waghule T, Rapalli VK, Gorantla S, et al. Nanostructured lipid carriers as potential drug delivery systems for skin disorders. Current Pharmaceutical Design. 2020;26(36):4569-4579.
108. Majumder N, G Das N, Das SK. Polymeric micelles for anticancer drug delivery. Therapeutic delivery. 2020;11(10):613-635.
109. Fang C-L, Aljuffali IA, Li Y-C, Fang J-Y. Delivery and targeting of nanoparticles into hair follicles. Therapeutic delivery 2014;5(9):991-1006.
110. Pelegrino M, Weller R, Chen X, Bernardes J, Seabra AB. Chitosan nanoparticles for nitric oxide delivery in human skin. MedChemComm. 2017;8(4):713-719.
111. Zhang Z, Tsai PC, Ramezanli T, Michniak‐Kohn BB. Polymeric nanoparticles‐based topical delivery systems for the treatment of dermatological diseases. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology. 2013;5(3):205-218.
112. Sun L, Liu Z, Wang L, et al. Enhanced topical penetration, system exposure and anti-psoriasis activity of two particle-sized, curcumin-loaded PLGA nanoparticles in hydrogel. Journal of Controlled Release. 2017;254:44-54.
113. Ramezanli T, Kilfoyle BE, Zhang Z, Michniak-Kohn BB. Polymeric nanospheres for topical delivery of vitamin D3. International Journal of Pharmaceutics. 2017;516(1-2):196-203.
114. Tabarzad M, Ghorbani-Bidkorbeh F. Dendrimers formulations to enhance skin drug delivery. Dendrimer-based nanotherapeutics: Elsevier; 2021:399-416.
115. Karthik P, Ezhilarasi P, Anandharamakrishnan C. Challenges associated in stability of food grade nanoemulsions. Critical reviews in food science and nutrition. 2017;57(7):1435-1450.
116. Belhaj N, Arab-Tehrany E, Linder M. Oxidative kinetics of salmon oil in bulk and in nanoemulsion stabilized by marine lecithin. Process Biochemistry. 2010;45(2):187-195.
117. Rehman FU, Shah KU, Shah SU, Khan IU, Khan GM, Khan A. From nanoemulsions to self-nanoemulsions, with recent advances in self-nanoemulsifying drug delivery systems (SNEDDS). Expert opinion on drug delivery. 2017;14(11):1325-1340.
118. Kamble P, Sadarani B, Majumdar A, Bhullar S. Nanofiber based drug delivery systems for skin: A promising therapeutic approach. Journal of Drug Delivery Science and Technology. 2017;41:124-133.
119. Rasouli R, Barhoum A, Bechelany M, Dufresne A. Nanofibers for biomedical and healthcare applications. Macromolecular bioscience. 2019;19(2):1800256.
120. Niu J, Chu Y, Huang Y-F, et al. Transdermal gene delivery by functional peptide-conjugated cationic gold nanoparticle reverses the progression and metastasis of cutaneous melanoma. ACS applied materials & interfaces. 2017;9(11):9388-9401.
121. Kumar H, Venkatesh N, Bhowmik H, Kuila A. Metallic nanoparticle: a review. Biomed J Sci Tech Res. 2018;4(2):3765-3775.
122. Rai M, Ingle AP, Birla S, Yadav A, Santos CAD. Strategic role of selected noble metal nanoparticles in medicine. Critical reviews in microbiology. 2016;42(5):696-719.
123. Iv M, Telischak N, Feng D, Holdsworth SJ, Yeom KW, Daldrup-Link HE. Clinical applications of iron oxide nanoparticles for magnetic resonance imaging of brain tumors. Nanomedicine. 2015;10(6):993-1018.
124. Nasrollahzadeh M, Sajadi SM. Green synthesis of copper nanoparticles using Ginkgo biloba L. leaf extract and their catalytic activity for the Huisgen [3+ 2] cycloaddition of azides and alkynes at room temperature. Journal of colloid and interface science. 2015;457:141-147.
125. Alsareii SA, Manaa Alamri A, AlAsmari MY, et al. Synthesis and characterization of silver nanoparticles from Rhizophora apiculate and studies on their wound healing, antioxidant, anti-inflammatory, and cytotoxic activity. Molecules. 2022;27(19):6306.
126. Shnoudeh AJ, Hamad I, Abdo RW, et al. Synthesis, characterization, and applications of metal nanoparticles. Biomaterials and bionanotechnology: Elsevier; 2019:527-612.
127. Begum SJ, Pratibha S, Rawat JM, et al. Recent advances in green synthesis, characterization, and applications of bioactive metallic nanoparticles. Pharmaceuticals. 2022;15(4):455.
Article Sidebar
Published
Jul 2, 2025
Article Details
How to Cite
1.
Nano-Enhanced Antibiotic Delivery for Skin Cancer Treatment: A Breakthrough in Nanomedicine. Pharm Pract (Granada) [Internet]. 2025 Jul. 2 [cited 2025 Jul. 16];23(2):1-19. Available from: https://pharmacypractice.org/index.php/pp/article/view/3117
Section
Original Research
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
How to Cite
1.
Nano-Enhanced Antibiotic Delivery for Skin Cancer Treatment: A Breakthrough in Nanomedicine. Pharm Pract (Granada) [Internet]. 2025 Jul. 2 [cited 2025 Jul. 16];23(2):1-19. Available from: https://pharmacypractice.org/index.php/pp/article/view/3117